(Q39592152)
Statements
Monitoring tumor response to antiangiogenic sunitinib therapy with 18F-fluciclatide, an 18F-labeled αVbeta3-integrin and αV beta5-integrin imaging agent (English)
Julian L Goggi
Lucy Allen
Jon Barnett
Matthew S Morrison
14 February 2011